Back
ESC Premium Access

Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial

Session: Poster Session 1 - Atrial fibrillation ablation and outcomes
Topic: Treatment
Speaker: Associate Professor M. Vamos (Szeged, HU)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)
0 follower

14 more presentations in this session

Catheter ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure

Speaker: Assistant Professor M. Samuel (Groningen, NL)

Access
Abstract
Slides
Like
Thumbnail

Clinical predictors for the improvement of left ventricular ejection fraction and prognosis after catheter ablation of atrial fibrillation in patients with systolic dysfunction

Speaker: Doctor K. Nagaoka (Kurume, JP)

Access
Abstract
Like
Thumbnail

Risk factors for the occurrence of stroke after atrial fibrillation ablation

Speaker: Professor S. Han (Anyang-Si- Gyeonggi-Do, KR)

Access
Abstract
Slides
Like
Thumbnail

The risk of dementia and catheter ablation for atrial fibrillation: a nationwide cohort study

Speaker: Associate Professor P. Yang (Seongnam, KR)

Access
Abstract
Slides
Like
Thumbnail

Impact of atrial fibrillation ablation procedural volume on complication and recurrence rate across european centers. An ESC EORP registry: atrial fibrillation long-term.

Speaker: Doctor E. Pagourelias (Thessaloniki, GR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Atrial fibrillation ablation and outcomes

Speakers: Associate Professor M. Vamos, Assistant Professor M. Samuel, Doctor K. Nagaoka, Professor S. Han, Associate Professor P. Yang...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources